Free Trial

Silexion Therapeutics (SLXN) Competitors

Silexion Therapeutics logo
$0.85 +0.01 (+1.43%)
As of 02:15 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

SLXN vs. MIRA, NNVC, FBLG, TPST, ALXO, QTTB, CVKD, TENX, CARA, and BCAB

Should you be buying Silexion Therapeutics stock or one of its competitors? The main competitors of Silexion Therapeutics include MIRA Pharmaceuticals (MIRA), NanoViricides (NNVC), FibroBiologics (FBLG), Tempest Therapeutics (TPST), ALX Oncology (ALXO), Q32 Bio (QTTB), Cadrenal Therapeutics (CVKD), Tenax Therapeutics (TENX), Cara Therapeutics (CARA), and BioAtla (BCAB). These companies are all part of the "pharmaceutical products" industry.

Silexion Therapeutics vs. Its Competitors

MIRA Pharmaceuticals (NASDAQ:MIRA) and Silexion Therapeutics (NASDAQ:SLXN) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, media sentiment, valuation, profitability, earnings, risk, institutional ownership and analyst recommendations.

MIRA Pharmaceuticals currently has a consensus target price of $14.00, indicating a potential upside of 702.29%. Silexion Therapeutics has a consensus target price of $5.00, indicating a potential upside of 485.48%. Given MIRA Pharmaceuticals' stronger consensus rating and higher possible upside, equities analysts clearly believe MIRA Pharmaceuticals is more favorable than Silexion Therapeutics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
MIRA Pharmaceuticals
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
3.33
Silexion Therapeutics
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Silexion Therapeutics' return on equity of 0.00% beat MIRA Pharmaceuticals' return on equity.

Company Net Margins Return on Equity Return on Assets
MIRA PharmaceuticalsN/A -341.08% -272.93%
Silexion Therapeutics N/A N/A -359.62%

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
MIRA PharmaceuticalsN/AN/A-$7.85M-$0.51-3.42
Silexion TherapeuticsN/AN/A-$16.44MN/AN/A

In the previous week, MIRA Pharmaceuticals and MIRA Pharmaceuticals both had 1 articles in the media. Silexion Therapeutics' average media sentiment score of 1.89 beat MIRA Pharmaceuticals' score of 1.87 indicating that Silexion Therapeutics is being referred to more favorably in the news media.

Company Overall Sentiment
MIRA Pharmaceuticals Very Positive
Silexion Therapeutics Very Positive

MIRA Pharmaceuticals has a beta of 1.72, indicating that its share price is 72% more volatile than the S&P 500. Comparatively, Silexion Therapeutics has a beta of 0.05, indicating that its share price is 95% less volatile than the S&P 500.

35.2% of MIRA Pharmaceuticals shares are owned by institutional investors. Comparatively, 11.0% of Silexion Therapeutics shares are owned by institutional investors. 6.7% of MIRA Pharmaceuticals shares are owned by insiders. Comparatively, 6.0% of Silexion Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

MIRA Pharmaceuticals beats Silexion Therapeutics on 9 of the 11 factors compared between the two stocks.

Get Silexion Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for SLXN and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SLXN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SLXN vs. The Competition

MetricSilexion TherapeuticsMED IndustryMedical SectorNASDAQ Exchange
Market Cap$7.42M$3.04B$5.71B$9.51B
Dividend YieldN/A2.40%4.60%3.99%
P/E RatioN/A21.1328.0720.02
Price / SalesN/A338.95459.47103.02
Price / CashN/A43.2336.5558.97
Price / Book-0.348.278.615.88
Net Income-$16.44M-$55.19M$3.24B$258.50M
7 Day Performance3.15%5.50%3.83%2.03%
1 Month Performance6.75%17.25%10.40%12.52%
1 Year PerformanceN/A4.61%34.13%19.07%

Silexion Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SLXN
Silexion Therapeutics
N/A$0.85
+1.4%
$5.00
+485.5%
N/A$7.42MN/A0.00N/APositive News
MIRA
MIRA Pharmaceuticals
2.61 of 5 stars
$1.54
+20.3%
$14.00
+809.1%
-26.3%$26.06MN/A-3.022High Trading Volume
NNVC
NanoViricides
0.3736 of 5 stars
$1.60
+14.7%
N/A-31.3%$25.72MN/A-2.2220High Trading Volume
FBLG
FibroBiologics
3.8148 of 5 stars
$0.64
+1.7%
$13.00
+1,931.3%
-86.2%$25.40MN/A-3.0510Positive News
Gap Up
TPST
Tempest Therapeutics
2.3329 of 5 stars
$6.90
-0.7%
$30.00
+334.8%
-71.7%$25.39MN/A-0.3820Positive News
ALXO
ALX Oncology
3.8534 of 5 stars
$0.47
-2.8%
$3.30
+603.9%
-91.3%$25.03MN/A-0.1940Positive News
QTTB
Q32 Bio
2.5652 of 5 stars
$2.03
-23.7%
$12.17
+499.3%
-93.6%$24.77M$1.16M-0.4139High Trading Volume
CVKD
Cadrenal Therapeutics
3.1265 of 5 stars
$12.50
-3.3%
$32.00
+156.0%
N/A$24.59MN/A-1.354Positive News
TENX
Tenax Therapeutics
1.8291 of 5 stars
$5.90
+1.7%
$17.50
+196.6%
+77.6%$24.47MN/A-2.389Positive News
CARA
Cara Therapeutics
0.2154 of 5 stars
N/AN/AN/A$24.33M$7.14M-0.2580Gap Down
High Trading Volume
BCAB
BioAtla
2.1404 of 5 stars
$0.40
+4.0%
$5.00
+1,153.1%
-78.0%$23.31M$11M-0.3360

Related Companies and Tools


This page (NASDAQ:SLXN) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners